Prosecution Insights
Last updated: April 19, 2026

BIONTECH SE

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17906448 ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES HILL, KEVIN KAI 1638 Non-Final OA Sep 15, 2022
17310459 TREATMENT INVOLVING CAR-ENGINEERED T CELLS AND CYTOKINES WEN, SHARON X 1641 Final Rejection Aug 04, 2021
17310463 CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELLS FOR THE TREATMENT OF CLDN6-EXPRESSING CANCERS CUNNINGCHEN, KATHLEEN MARY 1646 Non-Final OA Aug 04, 2021

Managing BIONTECH SE's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month